3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Myelodysplastic Syndromes
1
Mycoses
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hematologic Diseases
1
Graft vs Host Disease
1
Genetic Predisposition to Disease
1
Candidiasis
1
Aspergillosis
1
Interventions
Cytarabine
19
Cyclophosphamide
18
venetoclax
15
fludarabine phosphate
14
Busulfan
14
Cyclosporine
12
Azacitidine
11
fludarabine
10
Peripheral Blood Stem Cell Transplantation
10
Granulocyte Colony-Stimulating Factor
10
Mycophenolic Acid
9
Filgrastim
9
Melphalan
8
Antilymphocyte Serum
8
Whole-Body Irradiation
7
Palliative Care
7
Idarubicin
6
Blood Specimen Collection
6
Methotrexate
5
Therapeutics
4
Specimen Handling
4
Radiotherapy
4
Methods
4
Early Intervention, Educational
4
Daunorubicin
4
Cord Blood Stem Cell Transplantation
4
thymoglobulin
3
Thiotepa
3
Tacrolimus
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myeloid, Acute
×
Fluconazole
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled